What type of study is this?

This is a Literature Review study.

September 10, 2025

Esophageal Large Cell Neuroendocrine Carcinoma: A brief Pathology Review of the Rare Tumor

Key Points

Esophageal large cell neuroendocrine carcinoma displays poor prognosis, indicating the need for improved diagnostic practices.
Current treatment approaches for LCNEC are sparse, emphasizing the urgency of further clinical research into targeted therapies.
Histological characteristics of LCNEC are unique compared to other esophageal cancers, which may complicate diagnoses.
Understanding the epidemiology and clinical presentation of LCNEC is critical to enhance patient management and outcomes.

Abstract

Esophageal Large Cell Neuroendocrine Carcinoma (LCNEC) is an exceedingly rare and aggressive neuroendocrine neoplasm (NEN) that originates in the esophagus. This review article aims to provide a concise yet comprehensive overview of LCNEC, touching upon its epidemiology, clinical presentation, diagnostic challenges, histological and molecular characteristics, and current approaches to treatment. LCNEC is marked by rapid progression and a poor prognosis, setting it apart from other esophageal cancers with its unique cellular morphology and neuroendocrine differentiation. Despite its rarity, understanding the pathology, clinical implications, and potential treatment strategies for LCNEC is crucial for improving patient outcomes. This review synthesizes current knowledge, highlighting the importance of accurate diagnosis and the need for further research to develop targeted therapies.

اسأل الذكاء الاصطناعي

Bookmark